Allergy School 2025: Biologicals, type 2 inflammation and eosinophil-associated diseases

AIFA Procedure

Official Italian Agency for AIFA Procedure*

Any Italian pharmaceutical company supporting or participating in a congress abroad is subjected to authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request for authorisation must be submitted 60 days before the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l.
Cristina Ghidoli

Via G. Ripamonti, 129
20141 Milan, Italy
Tel. +39 02 56601.1
FAX +39 02-70048585
e-mail: aifa@aimgroup.eu or c.ghidoli@aimgroup.eu

As the event will take place in Italy it is mandatory for foreign Pharmaceutical Companies to register in AIFA in order to submit the application to obtain AIFA authorisation and to be able to participate as sponsor at the meeting. Sponsors should inform EAACI Sponsorship by 07/05/2025 if they have to submit an AIFA application. The 4th July 2025 is the last day for sponsor to submit an AIFA application.